BRIEF published on 09/30/2024 at 09:06, 1 month 21 days ago VOQUZ Labs AG: H1 '24 Performance and Future Prospects VOQUZ Labs AG EBITDA Growth H1 '24 Report VisoryQ S4/HANA Transformation
PRESS RELEASE published on 09/30/2024 at 09:01, 1 month 21 days ago Original-Research: VOQUZ Labs AG (von NuWays AG): BUY VOQUZ Labs AG releases final H1 '24 report, with sales up by 25% yoy and EBITDA at €0.3m. Confirms FY guidance of 10-20% top-line growth and 15-20% EBITDA margin EBITDA Sales Growth VOQUZ Labs AG FY Guidance H1 Report
BRIEF published on 08/15/2024 at 09:06, 3 months 6 days ago VOQUZ Labs AG Delivers Strong Preliminary H1 Results and Reaffirms BUY Rating EBITDA Margin Sales Growth NuWays AG H1 Results VOQUZ Labs
PRESS RELEASE published on 08/15/2024 at 09:01, 3 months 6 days ago Original-Research: VOQUZ Labs AG (von NuWays AG): BUY VOQUZ Labs AG shows strong H1 results with 24.9% sales growth and increased EBITDA margin. Partnership with PwC Germany and new product launch expected to drive future growth EBITDA Margin Sales Growth VOQUZ Labs AG H1 Results PwC Germany
BRIEF published on 04/10/2024 at 09:07, 7 months 11 days ago VOQUZ Labs AG Foresees Strong Growth and Continues M&A Strategy VOQUZ Labs AG Financial Analysis Stock Market Mergers & Acquisitions S/4HANA Transformation
PRESS RELEASE published on 04/10/2024 at 09:02, 7 months 11 days ago Original-Research: VOQUZ Labs AG (von NuWays AG): Kaufen Update on VOQUZ Labs AG after the acquisition of NuWays AG, showcasing strong momentum with growth in key solutions and M&A strategy. Analyst recommends 'Kaufen' (Buy) with a target price of EUR 22.00 Acquisition VOQUZ Labs AG NuWays AG Growth Analyst Recommendation
BRIEF published on 03/22/2024 at 09:07, 7 months 30 days ago VOQUZ Labs AG Partners with PwC to Accelerate Market Penetration of remQ Software VOQUZ Labs AG SAP PwC Partnership RemQ Software ERP Transition
PRESS RELEASE published on 03/22/2024 at 09:02, 7 months 30 days ago Original-Research: VOQUZ Labs AG (von NuWays AG): Kaufen VOQUZ Labs AG announces strategic partnership with PwC Solutions Germany to market remQ software for SAP customers. Analyst: Philipp Sennewald recommends buying with a target price of EUR 22.00. Potential growth expected VOQUZ Labs AG PwC Partnership RemQ Software SAP Customers Financial Incentives
BRIEF published on 03/07/2024 at 09:06, 8 months 14 days ago VOQUZ Labs AG Receives "BUY" Rating with Promising Yearly Outlook from NuWays AG VOQUZ Labs AG NuWays AG Financial Analysis Market Outlook Stock Recommendation
PRESS RELEASE published on 03/07/2024 at 09:01, 8 months 14 days ago Original-Research: VOQUZ Labs AG (von NuWays AG): BUY VOQUZ Labs AG announces strong results for FY '23 with promising outlook for FY '24. H2 sales up 16% yoy, EBITDA positive at €0.4m. Target price increased to €22. Recommendation: BUY Buy Recommendation VOQUZ Labs AG FY '23 Results FY '24 Outlook Strong Sales Growth
Published on 11/21/2024 at 14:15, 9 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 24 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 24 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 24 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 7 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 9 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 48 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 26 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 4 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 39 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 39 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
